Corinna Schüß
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Corinna Schüß has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Annette Gabriele Beck‐Sickinger
Institute of Biochemistry Leipzig University Leipzig Germany
2 shared publications - Anette Kaiser
Department of Anesthesiology and Intensive Care, University of Leipzig Medical Center, Leipzig, Germany
1 shared publication - Anne Diemar
Institute of Biochemistry, Faculty of Life Sciences, Leipzig University, Leipzig, Germany
1 shared publication Annette G. Beck-Sickinger
Institute of Biochemistry, Faculty of Life Sciences, Leipzig University, Germany
1 shared publication- Beili Wu
State Key Laboratory of Drug Research, State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
1 shared publication - Charles David Weaver
Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA
1 shared publication
Latest Publications
- Open Access
- 13 January 2026
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 83 (1)
The pathway-independent positive allosteric modulator C1 allows for the identification of active Y4 receptor relevant positions
The neuropeptide Y 4 receptor (Y 4 R) and its endogenous ligand pancreatic polypeptide (PP) are primarily involved in the regulation of satiety and energy balance and present relevant pharmacological targets. We characterized the novel Y 4 R positive allosteric modulator C1 that enhances Y 4 R G-protein signaling, ligand binding, and arrestin-3 recruitment to Y 4 R. Comparison with a close analog revealed the structural importance of an ethyl acetate moiety for Y 4 R affinity and PAM activity at the G-protein pathway. C1 shows a high selectivity for the Y 4 R, while signaling of the related subtypes Y 1 R, Y 2 R, and Y 5 R is not affected. Y 4 R G-protein signaling is even potentiated by the low-affinity agonists neuropeptide Y and peptide YY. Binding affinity of the endogenous ligands to Y 4 R is enhanced by C1, indicating a stabilization of the ligand-bound Y 4 R conformation. Using Y 4 R/Y 1 R chimera, important Y 4 R domains for C1 activity were identified. Single point mutagenesis and computational docking pinpointed hot-spot residues at Y 4 R important for stabilizing the active ligand-bound conformation.
- 13 January 2026
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 83 (1)
Open AccessThe pathway-independent positive allosteric modulator C1 allows for the identification of active Y4 receptor relevant positions
The neuropeptide Y 4 receptor (Y 4 R) and its endogenous ligand pancreatic polypeptide (PP) are primarily involved in the regulation of satiety and energy balance and present relevant pharmacological targets. We characterized the novel Y 4 R positive allosteric modulator C1 that enhances Y 4 R G-protein signaling, ligand binding, and arrestin-3 recruitment to Y 4 R. Comparison with a close analog revealed the structural importance of an ethyl acetate moiety for Y 4 R affinity and PAM activity at the G-protein pathway. C1 shows a high selectivity for the Y 4 R, while signaling of the related subtypes Y 1 R, Y 2 R, and Y 5 R is not affected. Y 4 R G-protein signaling is even potentiated by the low-affinity agonists neuropeptide Y and peptide YY. Binding affinity of the endogenous ligands to Y 4 R is enhanced by C1, indicating a stabilization of the ligand-bound Y 4 R conformation. Using Y 4 R/Y 1 R chimera, important Y 4 R domains for C1 activity were identified. Single point mutagenesis and computational docking pinpointed hot-spot residues at Y 4 R important for stabilizing the active ligand-bound conformation.
- Open Access
- 24 February 2024
- Published by Elsevier in Neuropeptides
- Vol. 105, 102416
Illuminating the neuropeptide Y4 receptor and its ligand pancreatic polypeptide from a structural, functional, and therapeutic perspective
- 24 February 2024
- Published by Elsevier in Neuropeptides
- Vol. 105, 102416
Open AccessIlluminating the neuropeptide Y4 receptor and its ligand pancreatic polypeptide from a structural, functional, and therapeutic perspective
- Open Access
- 6 May 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (18) , eabm1232
Receptor-specific recognition of NPY peptides revealed by structures of NPY receptors
In response to three highly conserved neuropeptides, neuropeptide Y (NPY), peptide YY, and pancreatic polypeptide (PP), four G protein–coupled receptors mediate multiple essential physiological processes, such as food intake, vasoconstriction, sedation, and memory retention. Here, we report the structures of the human Y 1 , Y 2 , and Y 4 receptors in complex with NPY or PP, and the G i1 protein. These structures reveal distinct binding poses of the peptide upon coupling to different receptors, reflecting the importance of the conformational plasticity of the peptide in recognizing the NPY receptors. The N terminus of the peptide forms extensive interactions with the Y 1 receptor, but not with the Y 2 and Y 4 receptors. Supported by mutagenesis and functional studies, subtype-specific interactions between the receptors and peptides were further observed. These findings provide insight into key factors that govern NPY signal recognition and transduction, and would enable development of selective drugs.
- 6 May 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (18) , eabm1232
Open AccessReceptor-specific recognition of NPY peptides revealed by structures of NPY receptors
In response to three highly conserved neuropeptides, neuropeptide Y (NPY), peptide YY, and pancreatic polypeptide (PP), four G protein–coupled receptors mediate multiple essential physiological processes, such as food intake, vasoconstriction, sedation, and memory retention. Here, we report the structures of the human Y 1 , Y 2 , and Y 4 receptors in complex with NPY or PP, and the G i1 protein. These structures reveal distinct binding poses of the peptide upon coupling to different receptors, reflecting the importance of the conformational plasticity of the peptide in recognizing the NPY receptors. The N terminus of the peptide forms extensive interactions with the Y 1 receptor, but not with the Y 2 and Y 4 receptors. Supported by mutagenesis and functional studies, subtype-specific interactions between the receptors and peptides were further observed. These findings provide insight into key factors that govern NPY signal recognition and transduction, and would enable development of selective drugs.